Takeda Pharmaceutical Co. Ltd. Said to Be in Talks to Buy Nycomed for up to $14 Billion

Takeda Pharmaceutical Co., Asia’s largest drugmaker, approached closely held Swiss competitor Nycomed about a possible takeover, said three people with knowledge of the situation.

 

The negotiations are at an advanced stage, said the people, who declined to be identified because the discussions are private. Takeda may pay more than 8 billion euros ($11.4 billion), said one person, while Nycomed may seek more than 10 billion euros, according to another. There’s no agreement yet and the talks could fail.

Back to news